5-(1-PROPYL-BUTYL)-[1,3,4]THIADIAZOL-2-YLAMINE
- $65 - $498.18
- Product name: 5-(1-PROPYL-BUTYL)-[1,3,4]THIADIAZOL-2-YLAMINE
- CAS: 299441-41-1
- MF: C9H17N3S
- MW: 199.32
- EINECS:
- MDL Number:MFCD02664106
- Synonyms:5-(1-PROPYLBUTYL)-1,3,4-THIADIAZOL-2-AMINE;5-(1-PROPYL-BUTYL)-[1,3,4]THIADIAZOL-2-YLAMINE;5-(Heptan-4-yl)-1,3,4-thiadiazol-2-amine;1,3,4-Thiadiazol-2-amine, 5-(1-propylbutyl)-
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- TRC
Package
- 5MG
- 100mg
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0075528
- Product description5-(1-PROPYLBUTYL)-1,3,4-THIADIAZOL-2-AMINE 95.00%
- Packaging5MG
- Price$498.18
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11151595
- Product description5-(1-Propylbutyl)-1,3,4-thiadiazol-2-amine 95+%
- Packaging1g
- Price$357
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP839925
- Product description5-(1-Propylbutyl)-1,3,4-thiadiazol-2-amine
- Packaging100mg
- Price$65
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP839925
- Product description5-(1-Propylbutyl)-1,3,4-thiadiazol-2-amine
- Packaging1g
- Price$330
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0075528 | 5-(1-PROPYLBUTYL)-1,3,4-THIADIAZOL-2-AMINE 95.00% | 5MG | $498.18 | 2021-12-16 | Buy |
Crysdot | CD11151595 | 5-(1-Propylbutyl)-1,3,4-thiadiazol-2-amine 95+% | 1g | $357 | 2021-12-16 | Buy |
TRC | P839925 | 5-(1-Propylbutyl)-1,3,4-thiadiazol-2-amine | 100mg | $65 | 2021-12-16 | Buy |
TRC | P839925 | 5-(1-Propylbutyl)-1,3,4-thiadiazol-2-amine | 1g | $330 | 2021-12-16 | Buy |
Properties
Boiling point :323.7±25.0 °C(Predicted)
Density :1.084±0.06 g/cm3(Predicted)
pka :3.73±0.10(Predicted)
Density :1.084±0.06 g/cm3(Predicted)
pka :3.73±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|